Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0FP0R
|
||||
Former ID |
DCL000437
|
||||
Drug Name |
Apaziquone
|
||||
Synonyms |
Apaziquonum; EOquin; Neoquin; E 09; EO 9; EO9; Apaziquone [USAN:INN]; Apaziquonum [INN-Latin]; E-09; EO 9 (pharmaceutical); EO-9; Eoquin (TN); NOR-701; Apaziquone (USAN/INN); E-85/050; E-85/053; (E)-5-(1-Azirinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione; 3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1H-indole-4,7-dione)prop-beta-en-alpha-ol; 5-(Azridin-1-yl)-3-(hydroxymethyl)-2-((1E)-3-hydroxyprop-1-enyl)-methyl-1H-indole-4,7-dione; 5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methylindole-4,7-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Non-invasive bladder cancer [ICD9: 188; ICD10:C67] | Phase 3 | [544745] | ||
Company |
Spectrum
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H16N2O4
|
||||
Canonical SMILES |
CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO
|
||||
InChI |
1S/C15H16N2O4/c1-16-10(3-2-6-18)9(8-19)13-14(16)12(20)7-11(15(13)21)17-4-5-17/h2-3,7,18-19H,4-6,8H2,1H3/b3-2+
|
||||
InChIKey |
MXPOCMVWFLDDLZ-NSCUHMNNSA-N
|
||||
CAS Number |
CAS 114560-48-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Human DNA | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.